ArticleTargeted oncology2019

Crizotinib in Chinese Patients with ROS1-Rearranged Advanced Non‒Small-Cell Lung Cancer in Routine Clinical Practice.

Chang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.